-+ 0.00%
-+ 0.00%
-+ 0.00%

*Johnson & Johnson: FDA Approves IMAAVY as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia

Dow Jones·08/24/2026 23:15:00

登录查看新闻详情